Incorporating risk attitude into Markov-process decision models: importance for individual decision making.
Most decision models published in the medical literature take a risk-neutral perspective. Under risk neutrality, the utility of a gamble is equivalent to its expected value and the marginal utility of living a given unit of time is the same regardless of when it occurs. Most patients, however, are not risk-neutral. Not only does risk aversion affect decision analyses when tradeoffs between short- and long-term survival are involved, it also affects the interpretation of time-tradeoff measures of health-state utility. The proportional time tradeoff under- or overestimates the disutility of an inferior health state, depending on whether the patient is risk-seeking or risk-averse (it is unbiased if the patient is risk-neutral). The authors review how risk attitude with respect to gambles for survival duration can be incorporated into decision models using the framework of risk-adjusted quality-adjusted life years (RA-QALYs). They present a simple extension of this framework that allows RA-QALYs to be calculated for Markov-process decision models. Using a previously published Markov-process model of surgical vs expectant treatment for benign prostatic hypertrophy (BPH), they show how attitude towards risk affects the expected number of QALYs calculated by the model. In this model, under risk neutrality, surgery was the preferred option. Under mild risk aversion, expectant treatment was the preferred option. Risk attitude is an important aspect of preferences that should be incorporated into decision models where one treatment option has upfront risks of morbidity or mortality.
Cher
D J
DJ
Division of General Internal Medicine, Palo Alto VA Health Care System, California, USA. cher@camis.stanford.edu
Miyamoto
J
J
Lenert
L A
LA
D000368:Aged; D003658:Decision Making, Computer-Assisted; D003661:Decision Support Techniques; D006801:Humans; D008297:Male; D008390:Markov Chains; D011183:Postoperative Complications / Q000209:etiology; D011468:Prostatectomy; D011470:Prostatic Hyperplasia / Q000601:surgery; D019057:Quality-Adjusted Life Years; D012309:Risk-Taking; D016019:Survival Analysis; D016896:Treatment Outcome